No Data
Third Quarter Report 2024
Express News | Porton Pharma Solutions and Yinosi have reached a global strategic cooperation.
The amount of funds raised for the investment project has been significantly reduced, and Yinoosi has tested the "temperature" of the CRO industry.
①Yinuosi originally planned to raise 1.602 billion yuan, but only raised 0.672 billion yuan in reality, leading to a significant reduction in the investment amount of some fundraising projects and the cancellation of the supplementary flow project. ②Due to the slowdown in investment and financing, china meheco group's research and development expenditure growth rate has also started to slow down, impacting the performance of many upstream CRO companies including Yinuosi.
Express News | Yinuo Think: There is no significant information that should be disclosed but has not been disclosed.
Express News | YinuoSi: The company and its subsidiaries have obtained GLP certification.
Express News | Yinuo: It is expected that the non-deductible net income will decline compared to last year in 2024.
No Data
No Data